| Name | Spire Healthcare Group |
|---|---|
| Epic | SPI |
| Isin | GB00BNLPYF73 |
| Index | UK250 UK350 |
| Industry | Medical Equipment and Services |
| Latest share price | 217.50p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £877.28 | Debt ratio | n/a |
| Shares in issue | 404.13 | Debt-to-equity ratio | n/a |
| P/E ratio | 54.3 | Assets / equity ratio | n/a |
| Total dividends per share | 0.50p | Price to book value | n/a |
| Dividend yield | 0.2 | ROCE | 5.87 |
| Dividend cover | 8.4 | EPS growth | n/a |
| Earning per share | 2.1 | 52-week high / low | 215.00p / 266.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2024-05-23 | 2024-06-21 | 2.10p |
| Final | 2023-05-25 | 2023-06-23 | 0.50p |
| Interim | 2019-11-14 | 2019-12-10 | 1.30p |
| Company name | Spire Healthcare Group |
|---|---|
| Address | 3 Dorset Rise, London, United Kingdom, EC4Y 8EN |
| Telephone | +44 (0)20 7427 9000 |
| Website | http://www.spirehealthcare.com |
| Director | Position |
|---|---|
| Mr Justin Ash | CEO |
| Mr Harbant Samra | CFO |
| Dr Ronnie van der Merwe | Non-Executive Director |
| Mr Martin Angle | Deputy Chairman |
| Mr Ian Cheshire | Non-Executive Chairman |
| Ms Debbie White | Senior Independent Director |
| Ms Dame Janet Husband | Independent Non-Executive Director |
| Prof Clifford (Cliff) Shearman | Independent Non-Executive Director |
| Ms Natalie Ceeney | Independent Non-Executive Director |
| Mr Paula Bobbett | Independent Non-Executive Director |
| Mr Jenny Kay | Independent Non-Executive Director |
| Assets £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Reporting date | 31/12/22 | 31/12/21 | 31/12/20 |
| Intangible asssets and goodwill | 345.8 | 334.8 | 317.8 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 1939.8 | 1890.6 | 1854.7 |
| Inventory / work in progress | 40.6 | 40.2 | 37.6 |
| Trade and other receivables | 100.5 | 99.2 | 101.4 |
| Cash and equivalents | 74.2 | 202.6 | 106.3 |
| Other current assets and asset held for resale | 3.6 | n/a | n/a |
| Total of all assets | 2159.8 | 2237.4 | 2104.8 |
| Liabilities £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Short term liabilities | 283.4 | 302.1 | 253.9 |
| Long term liabilities | 1151.3 | 1230.5 | 1144.3 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 1434.7 | 1532.6 | 1398.2 |
| Net assets £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Net assets | 725.1 | 704.8 | 706.6 |
| Equity £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Share capital | 4 | 4 | 4 |
| Minority interests | -5.9 | -4.8 | n/a |
| Retained earnings | -485.7 | -496.1 | -496.4 |
| Share premium account | 830 | 826.9 | 826.9 |
| Total equity | 725.1 | 704.8 | 706.6 |
| Income £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 95.4 | 87 | -146.2 |
| Pre-tax profit | 3.9 | -1.9 | -231 |